Adding navitoclax to the standard TB treatment (IMAGE)
Caption
In a Johns Hopkins Children’s Center study, the addition of navitoclax to the standard TB treatment significantly increased apoptosis (shown in red) in several lung cell populations including phagocytic cells (shown in blue). Pink areas reflect overlapping red and blue signals.
Credit
Singh et al. Nature Communications 2025
Usage Restrictions
none
License
Original content